Primary comparison for continuous passive motion (CPM) vs no CPM
- Continuous passive motion following total knee arthroplasty in people with arthritis 2014 · Cochrane Headline outcomes onlyno estimate extracted8 studies · 414 participantsLow
It is very uncertain whether primary comparison for continuous passive motion (CPM) changes manipulation under anaesthesia Counts of manipulation under… compared with no CPM (very low certainty).
Primary comparison for continuous passive motion (CPM) showed no clear difference in adverse events Counts of adverse events compared with no CPM (low certainty).
It is very uncertain whether continuous negative extrathoracic pressure ventilation changes less than 30% FiO2 after 1 hour of therapy compared with control (very low certainty).
It is very uncertain whether continuous negative extrathoracic pressure ventilation changes intermittent positive pressure ventilation during hospital stay compared with control (very low certainty).
It is very uncertain whether continuous negative extrathoracic pressure ventilation changes CPAP during hospital stay compared with control (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
High‐volume continuous veno‐venous hemofiltration (CVVH) showed no clear difference in all‐cause mortality compared with standard CVVH (low certainty).
It is very uncertain whether high‐volume continuous veno‐venous hemofiltration (CVVH) changes adverse events compared with standard CVVH (very low certainty).
The review found no eligible studies for this question.
Continuous phenobarbital showed no clear difference in recurrent seizure at 18 months compared with placebo or no treatment (moderate certainty).
Continuous phenobarbital probably leads to lower recurrent seizure at 24 months compared with placebo or no treatment (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether continuous phenobarbital changes recurrent seizure at 60 months or greater compared with placebo or no treatment (very low certainty).